Daily Bulletins
At the end of every day of the conference (1 - 3 December) jargon-free bulletins will be posted here, giving the highlights of the clinical and scientific sessions of the meeting.
Day 1: Read the news from the first day
The first day of the conference included presentations on the exciting field of neurogenomics in the scientific sessions and cultural approaches to caring for people with MND in the clinical meeting.
In his speech Mr Joe Pantalone thanked the delegates for all their hard work and dedication in researching treatments for ALS/MND.
Prof Strong presented his argument that ALS/MND is a combination of disorders by outlining how both anecdotal and evidence-based observations of patients with ALS/MND.
The first ever stem cell derived human motor neurones that mimic ALS were described in a presentation of the first day of the Symposium.
The first session on palliative care at the 18th International Symposium on ALS/MND paid tribute to the work of Dr Balfour Mount, MD, one of the pioneers of palliative care.
Dr David Oliver from the UK outlined the findings from a study looking into end of life care in the UK, USA and Japan during a presentation on the first day of the 18th International Symposium on ALS/MND.
Melanie Fried-Oken outlined how advances in technology has widely increased communication options for people with MND.
Day 2: Read the news from the second day
Read the news from the second day of the International Symposium
Dr Timothy Williams reported that many healthcare professionals fear that even the offer of PEG feeding may be construed as an unwelcome landmark on disease deterioration.
Researchers from The Netherlands and the UK respectively presented their latest results on the search for these elusive susceptibility genes.
Health professionals are increasingly attempting to understand illness from the patient’s perspective.
Louise Locock presented the findings of a qualitative study interviewing with 40 people living with MND.
Day 3: Read the news from the third day
Read the news from the final day of the Symposium
Combining drugs that affect different aspects of neurodegeneration may be necessary to have a meaningful affect on treating ALS/MND.
How these proteins form and how they are removed in MND was one of the topics of a scientific session of on the last day of the International Symposium on ALS/MND.
During a presentation at the 18th International Symposium Dutch neurologist, Dr van den Berg outlined the results from his clinical assessment of 12 patients who travelled to Beijing for stem cell therapy.
Information for researchers
